Mirati Therapeutics, Inc. announced the appointment of Maya Martinez-Davis to the Company's Board of Directors, effective immediately. Ms. Martinez-Davis is the President of BioPharma Latin America for Merck KGaA, Darmstadt, Germany driving the pharmaceutical business in a variety of developed and emerging markets in 14 countries. Previously, she was the Senior Vice President and Head of Global Oncology at Merck KGaA, Darmstadt, Germany and led the global oncology franchise strategy and aligned the research and development, business development and technical operations across the organization, including the global launch for avelumab.